CA

CARsgen Therapeutics Holdings Limited

科濟藥業控股有限公司

Health & Medical

General Information

Official company information

Business Registration (BR) Number
72723852
Company Registration Number
F0029095
Company Age
4 years
Registration Date
Registered Address
5/F, MANULIFE PLACE, 348 KWUN TONG ROAD KLN, HONG KONG
Date of Name Change
12 May 2021
Email
N/A
Website

Official company website with more information about products, services, and contact details.

About CARsgen Therapeutics Holdings Limited

Company profile and description

CARsgen Therapeutics Holdings Limited is a biotechnology company focused on discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors. They are developing autologous and allogeneic CAR-T product candidates. The company was founded in 2014 and is headquartered in Shanghai, China. Their mission is to be a global biopharmaceutical leader that provides innovative and differentiated cell therapies for patients worldwide and makes cancer and other diseases curable.

Category

Business category and classification details

Primary Category
Health & Medical
Description
Providers of medical, dental, therapeutic, and other health-related services, including hospitals, clinics, private practices, and pharmacies.

Additional Information

Detailed company information and status

Company Type
Registered non-Hong Kong company
Location Code
HK
Company Origin
Foreign Company
Registration Status
Active
Website
https://www.carsgen.com/

Company Contacts

Key contacts and leadership

Name & Position Email Contact Number Fax Number

Request For Information Free

We will attempt to gather this information through our sources

Current requests: 0

Similar Companies

Companies in the same industry or category

View All in Health & Medical

In the News

Recent media coverage and press mentions

No recent media coverage

No recent news articles found for CARsgen Therapeutics Holdings Limited

Social Media

Connect with CARsgen Therapeutics Holdings Limited